/IRBIS, Natalya Kuznetsova, May 24, 06/ - Chimfarm JSC (Shymkent),
within listing requirements, has presented to Kazakhstan stock exchange
(KASE) its financial statements for the first quarter of 2006. Similar
indicators for 2005 are given in parentheses.
According to the presented data, the company's net income for the
mentioned period was KZT6,588 m., whereas for the first quarter of 2005 the
company got net income at KZT15,193 m.
According to data of Chimfarm JSC income from sale of ready products
(works, services) for the first quarter of current year was KZT588,366 m.
(KZT501,025 m.) while its prime cost was KZT339,172 m. (KZT319,458 m.).
Assets of the company as of April 1, 2006 were KZT6,657.3 m. in
comparison with KZT6,566.1 m. as of January 1, 2006.
Equity capital of the company as of April 1, 2006 reached KZT1,853.8 m.
compared to KZT1,925.7 m. as of the beginning of the year. Authorized
capital has not changed since the beginning of the year and as of the end of
the first quarter is estimated by the company at KZT1,557.7 m. Company's
unpaid authorized capital was absent, according to balance sheet data.
Full financial statements of Chimfarm JSC for the first quarter of 2006 is
available on KASE's web-site at
http://www.kase.kz/emitters/chfm.asp
Securities of Chimfarm JSC are traded in KASE's official "A" listing category,
bonds - in "A" category, shares - in "B" category.
Company's primary activities - production of drugs; quality control and
conducting of certification tests of drugs, ethyl alcohol and distillery
production by the laboratory, which has passed accreditation; sale of
chemical-pharmaceutical preparations, medical, sanitary-hygienic means
and medical makings; preparation, purchasing of medical raw stuff;
production and sale of other goods.
[2006-05-24]